HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $940,411 | +10.6% | 10,498 | +5.1% | 0.24% | +16.1% |
Q2 2023 | $850,379 | +1.3% | 9,988 | -1.5% | 0.21% | -3.2% |
Q1 2023 | $839,334 | +15.5% | 10,143 | +9.8% | 0.22% | +10.7% |
Q4 2022 | $726,569 | -18.2% | 9,238 | -23.0% | 0.20% | -23.6% |
Q3 2022 | $888,000 | +11.4% | 11,993 | -1.9% | 0.26% | +15.7% |
Q2 2022 | $797,000 | +0.4% | 12,224 | -2.7% | 0.22% | +20.5% |
Q1 2022 | $794,000 | +19.2% | 12,558 | +0.0% | 0.18% | +24.2% |
Q4 2021 | $666,000 | -32.7% | 12,556 | -10.5% | 0.15% | -39.4% |
Q3 2021 | $990,000 | +15.5% | 14,026 | +9.1% | 0.25% | +12.3% |
Q2 2021 | $857,000 | -26.4% | 12,861 | +22.7% | 0.22% | -31.1% |
Q1 2021 | $1,164,000 | +49.6% | 10,482 | +60.0% | 0.32% | +43.2% |
Q4 2020 | $778,000 | +102.1% | 6,552 | +48.3% | 0.22% | +82.0% |
Q3 2020 | $385,000 | +38400.0% | 4,418 | +27512.5% | 0.12% | – |
Q1 2018 | $1,000 | -88.9% | 16 | -92.9% | 0.00% | -100.0% |
Q4 2016 | $9,000 | +12.5% | 224 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $8,000 | +300.0% | 224 | +322.6% | 0.00% | +100.0% |
Q2 2016 | $2,000 | – | 53 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |